Leishmaniasis is regarded as a neglected tropical disease by World Health Organization
(WHO) and is ranked next to malaria as the deadliest protozoan disease. The primary …

The liposomal amphotericin B (AmB) formulation, AmBisome®, still represents the best
therapeutic option for cutaneous and visceral leishmaniasis. However, its clinical efficacy …

Leishmaniasis is a tropical infectious disease caused by the protozoan Leishmania parasite.
The disease is transmitted by female sand flies and, depending on the infecting parasite …

Ethnopharmacological relevance Pulsatilla decoction is a traditional Chinese medicine from
Shang Han Lun that has been reported to have therapeutic efficacy in vulvovaginal …

Cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (ML) show clinical
spectra that can range from a localized lesion (with a spontaneous healing process) to …

Nanomedicine strategies were first adapted and successfully translated to clinical
application for diseases, such as cancer and diabetes. These strategies would no doubt …

Type III interferons (IFN-λ) are antiviral and immunomodulatory cytokines that have been
best characterized in respiratory and gastrointestinal infections, but the effects of IFN-λ …

Cutaneous leishmaniasis caused by Leishmania parasites exhibits a wide range of clinical
manifestations. Although parasites influence disease severity, cytolytic CD8 T cell responses …

Leishmania is an intracellular protozoan transmitted by sand fly vectors; it causes
cutaneous, mucocutaneous, or visceral disease. Its growth and survival are impeded by type …

Leishmaniasis is a group of vector-borne diseases caused by intracellular protozoan
parasites belonging to the genus Leishmania. Leishmania parasites can employ different …